<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03096652</url>
  </required_header>
  <id_info>
    <org_study_id>R/16.06.54</org_study_id>
    <nct_id>NCT03096652</nct_id>
  </id_info>
  <brief_title>A Modified Approach for Morbid Obese With Gynecologic Cancer</brief_title>
  <official_title>Gynecologic Cancer: a Modified Approach for Morbid Obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing standard midline approach with the modified approach in management of morbid obese
      patients with gynecologic cancers.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oncologic outcome</measure>
    <time_frame>2 weeks</time_frame>
    <description>measured by number of lymph nodes retrieved and rate of optimal debulking.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative procedure related morbidity</measure>
    <time_frame>1 month</time_frame>
    <description>Wound and chest complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>1 day</time_frame>
    <description>intraoperative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Malignant Neoplasm of Cervix, Endometrium and Ovary</condition>
  <arm_group>
    <arm_group_label>Midline approach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard midline incision, then optimal debulking (hysterectomy + lymphadenectomy +/- omentectomy).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Modified approach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Panniculectomy with vertical incision of the rectus sheath then optimal debulking (hysterectomy + lymphadenectomy +/- omentectomy).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Approach for cancer resection</intervention_name>
    <arm_group_label>Midline approach</arm_group_label>
    <arm_group_label>Modified approach</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Resectable (ovarian, endometrial, cervical) cancers.

          2. Anaesthetically fit (ASA 1 and 2).

          3. Abdominal pannus below symphysis pubis.

        Exclusion Criteria:

          1. Non resectable gynecologic cancer.

          2. Unfit patients.

          3. Patients who refuse to share in the trial.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Islam H Metwally, MSc, MRCS</last_name>
    <phone>01002985865</phone>
    <phone_ext>020</phone_ext>
    <email>drislamhany@mans.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Oncology center Mansoura University</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Islam H Metwally, MSc, MRCS</last_name>
      <phone>01002985865</phone>
      <phone_ext>020</phone_ext>
      <email>drislamhany@mans.edu.eg</email>
    </contact>
    <investigator>
      <last_name>Ahmed AbdAllah, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amr F Elalfy, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shadi Awny, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohamed Zuhdy, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mahmoud Mostafa, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sameh Roshdy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Islam H Metwally, MSc, MRCS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2017</study_first_submitted>
  <study_first_submitted_qc>March 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2017</study_first_posted>
  <last_update_submitted>March 24, 2017</last_update_submitted>
  <last_update_submitted_qc>March 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Islam Hany Metwally</investigator_full_name>
    <investigator_title>Assistant lecturer of surgical oncology</investigator_title>
  </responsible_party>
  <keyword>gynecologic cancer - panniculectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

